Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2850 of 3284 entries
View as:

A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02560363 Org: User:
Start: 11/30/15 End: 01/31/16 Due: 01/31/17

Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT00392288 Org: User:
Start: 09/30/06 End: 02/29/08 Due: 02/28/09

Boosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Transition Bundle

Phase: N/A Priority: Normal
NCT ID: NCT06646419 Org: User:
Start: 11/13/24 End: 08/31/26 Due: 08/31/27

AZD0585 Phase III Long-term Study in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02463071 Org: User:
Start: 06/10/15 End: 03/11/17 Due: 03/11/18

PreAsthmaControl (PAC)

Phase: N/A Priority: Normal
NCT ID: NCT00234390 Org: User:
Start: 11/30/98 End: 12/31/04 Due: 12/31/05

Real-world, 52-week Prospective Study to Capture the Reasons for Switch to Triple Combination Therapy, Assess the Clinical and Patient Reported Outcomes in Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Trixeo Aerosphere™ in Routine Care Settings in Greece

Phase: N/A Priority: Normal
NCT ID: NCT05915182 Org: User:
Start: 07/21/23 End: 03/28/25 Due: 03/28/26

Prevalence and Risk Factors in Unipolar Depression Patients Without Remission After One Antidepressant Trial

Phase: N/A Priority: Normal
NCT ID: NCT01887639 Org: User:
Start: 09/30/13 End: 09/30/14 Due: 09/30/15

AZD0837 Extended Release (ER) Japan Study

Phase: N/A Priority: Normal
NCT ID: NCT00904800 Org: User:
Start: 05/31/09 End: 06/30/09 Due: 06/30/10

A Real World Study to Capture Clinical and Patient Centered Outcomes in Adults With Severe Eosinophilic Asthma Treated With Benralizumab.

Phase: N/A Priority: Normal
NCT ID: NCT05440656 Org: User:
Start: 06/29/22 End: 04/13/25 Due: 04/13/26

European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes

Phase: N/A Priority: Normal
NCT ID: NCT01239589 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03737643 Org: User:
Start: 01/04/19 End: 03/30/28 Due: 03/30/29

Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03509012 Org: User:
Start: 05/02/18 End: 01/08/25 Due: 01/08/26

AZD9056 Relative Bioavailability Study

Phase: N/A Priority: Normal
NCT ID: NCT00908934 Org: User:
Start: 05/31/09 End: 07/31/09 Due: 07/31/10

Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study

Phase: N/A Priority: Normal
NCT ID: NCT00228514 Org: User:
Start: 02/29/04 End: 07/31/07 Due: 07/31/08

To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328

Phase: N/A Priority: Normal
NCT ID: NCT00752830 Org: User:
Start: 09/30/08 End: 10/31/08 Due: 10/31/09

Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

Phase: N/A Priority: Normal
NCT ID: NCT00042458 Org: User:
Start: 04/30/02 End: 03/31/03 Due: 03/31/04

Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00692874 Org: User:
Start: 06/30/08 End: 09/30/10 Due: 09/30/11

REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania

Phase: N/A Priority: Normal
NCT ID: NCT06170671 Org: User:
Start: 12/13/23 End: 09/30/28 Due: 09/30/29

Forxiga Tablets Specific Clinical Experience Investigation for Elderly

Phase: N/A Priority: Normal
NCT ID: NCT02200627 Org: User:
Start: 09/30/14 End: 04/30/16 Due: 04/30/17

Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)

Phase: N/A Priority: Normal
NCT ID: NCT00163423 Org: User:
Start: 11/30/04 End: 01/31/06 Due: 01/31/07

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00668083 Org: User:
Start: 09/30/07 End: 07/31/08 Due: 07/31/09

Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)

Phase: N/A Priority: Normal
NCT ID: NCT00314509 Org: User:
Start: 07/31/05 End: 01/31/06 Due: 01/31/07

A Phase I Study to Assess the Pharmacodynamics of Oral AR-C165395XX in Subjects With Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT02367066 Org: User:
Start: 03/31/15 End: 05/31/15 Due: 05/31/16

Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02260661 Org: User:
Start: 11/30/14 End: 07/31/16 Due: 07/31/17

Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05790304 Org: User:
Start: 02/20/23 End: 02/22/24 Due: 02/22/25